Cintas Corporation
—- Market cap
- $80.63B
- Debt
- —
- Cash
- −$289.02M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CTAS stock price vs SBAC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SBAC's multiple
Needs SBAC P/E.
Implied fair value · at CTAS's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Cintas Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SBA COMMUNICATIONS CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNIFIRST CORP
CTAS vs UNF
ABM INDUSTRIES INC /DE/
CTAS vs ABM
Aramark
CTAS vs ARMK
W.W. GRAINGER, INC.
CTAS vs GWW
INTUIT INC.
CTAS vs INTU
IRON MOUNTAIN INC
CTAS vs IRM
AMERICAN TOWER CORP /MA/
CTAS vs AMT
ORACLE CORP
CTAS vs ORCL
EQUINIX INC
CTAS vs EQIX
Prologis, Inc.
CTAS vs PLD
WEYERHAEUSER CO
CTAS vs WY
COSTAR GROUP, INC.
CTAS vs CSGP
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CTAS can sustain its 7.7% revenue growth and 32.4% ROIC enough to justify a premium multiple, then hold rather than add aggressively because the current price already sits above the P/E-derived implied value of $82.86 and above SBAC-implied range high of $179.71.
CTAS trades at a materially richer earnings multiple than SBAC, with P/E of 41.2x versus 18.8x, even though the implied price from the P/E framework is only $82.86 versus a current price of $181.40. The valuation picture is mixed because CTAS is cheaper on EV/Revenue than SBAC but more expensive on EV/EBITDA, suggesting the market is paying up for CTAS’s profitability and growth quality.
Supporting Metrics